Targeting XIAP bypasses Bcl-2-mediated resistance to TRAIL and cooperates with TRAIL to suppress pancreatic cancer growth in vitro and in vivo.

Source:http://linkedlifedata.com/resource/pubmed/id/18829553

Cancer Res. 2008 Oct 1 68 19 7956-65

Download in:

View as

General Info

PMID
18829553